A61P 15/06
Antiabortive agents
Official title: Antiabortive agents; Labour repressants
A61P15/06 (Antiabortive agents) appears on 922 US grants and 1,372 published applications in this corpus.
Search patents in A61P- Granted patents
- 922
- Published applications
- 1,372
- Assignees
- 483
- Inventors
- 2,525
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 5 | 0 |
| 1997 | 12 | 0 |
| 1998 | 6 | 0 |
| 1999 | 11 | 0 |
| 2000 | 20 | 0 |
| 2001 | 16 | 5 |
| 2002 | 22 | 48 |
| 2003 | 29 | 68 |
| 2004 | 34 | 101 |
| 2005 | 32 | 79 |
| 2006 | 43 | 91 |
| 2007 | 47 | 103 |
| 2008 | 55 | 89 |
| 2009 | 65 | 115 |
| 2010 | 56 | 142 |
| 2011 | 64 | 89 |
| 2012 | 64 | 76 |
| 2013 | 58 | 52 |
| 2014 | 56 | 47 |
| 2015 | 33 | 43 |
| 2016 | 37 | 38 |
| 2017 | 35 | 29 |
| 2018 | 20 | 25 |
| 2019 | 17 | 21 |
| 2020 | 25 | 24 |
| 2021 | 16 | 27 |
| 2022 | 12 | 13 |
| 2023 | 9 | 10 |
| 2024 | 8 | 19 |
| 2025 | 10 | 9 |
| 2026 | 4 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- FcRn antibodies and methods of use thereof16 Jun 2026US 12,655,209 B2Momenta Pharmaceuticals, Inc.
- Fc region variant2 Jun 2026US 12,643,937 B2Chugai Seiyaku Kabushiki Kaisha
- Complement component C5 iRNA compositions and methods of use thereof31 Mar 2026US 12,590,305 B2Alnylam Pharmaceuticals, Inc.
- Compositions and methods for treating CNS disorders20 Jan 2026US 12,527,805 B1
- Hydroxyprogesterone caproate compositions and methods of use in preventing preterm birth23 Dec 2025US 12,502,396 B2
- Use of resveratrol in preparation of product for preventing and/or treating unexplained recurrent spontaneous abortion3 Sep 2026US 2026/0256713 A1The First Affiliated Hospital of Anhui Medical University
- Fc region variant27 Aug 2026US 2026/0250360 A1Chugai Seiyaku Kabushiki Kaisha
- Microbiome-based informed method to formulate live biotherapeutics20 Aug 2026US 2026/0240920 A1University of Maryland, Baltimore
- Vaginal microbiota compositions for treating recurrent pregnancy loss6 Aug 2026US 2026/0224648 A1
- Vaginal microbiota compositions for use in infertility23 Jul 2026US 2026/0207684 A1
Most cited
By later US patents
- Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents617US 6,294,192 B1Lipocine Inc. · 2001
- Compositions and methods for improved delivery of hydrophobic agents332US 6,451,339 B2Lipocine Inc. · 2002
- Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents332US 6,603,008 B1Pfizer Inc. · 2003
- Downmodulating an immune response with multivalent antibodies to PD-1309US 6,808,710 B1Dana-Farber Cancer Institute, Inc. · 2004
- PD-1, a receptor for B7-4, and uses therefor156US 7,101,550 B2Dana-Farber Cancer Institute, Inc. · 2006